Skip to main content
Erschienen in: Neurocritical Care 3/2010

01.12.2010 | Original Article

Occurrence of Post-Acute Recanalization and Collateral Formation in Patients with Cerebral Venous and Sinus Thrombosis. A Serial Venographic Study

verfasst von: Abeer Farrag, Muna Irfan, Gaurav K. Guliani, Nauman Tariq, Robert A. Taylor, M. Fareed K. Suri, Adnan I. Qureshi

Erschienen in: Neurocritical Care | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The underlying mechanism for symptomatic recovery in patients with cerebral venous and sinus thrombosis (CVST) is not clear, although post-acute recanalization and collateral formation have been proposed as possible mechanisms. To identify the occurrence of recanalization and collateral formation among survivors of CVST and explore its association with symptomatic recovery.

Methods

We identified all the patients admitted with CVST over a 5-year period and who underwent initial magnetic resonance (MR) or computed tomographic (CT) venography and a follow-up CT or MR venography between 3 and 12 months after onset. All the images were reviewed by a single observer using the classification for recanalization proposed by Qureshi grade I—partial recanalization of one or more occluded dural sinus with improved flow or visualization of branches; grade II—complete recanalization of one sinus but persistent occlusion of the other sinuses [A—no residual flow, B—non occlusive flow]; grade III—complete recanalization and for collateral formation (grade I—collaterals bypass occluded segment of dural venous sinus but connect within the same sinus; grade II—collaterals bypass occluded segment but connect with a different sinus; grade III—collaterals bypass the occluded segment and connect with different circulation).

Results

A total of 39 patients with CVST (mean age 34.82 [±17.1 SD]; 19 were men) had an initial and follow-up venographic study performed. Of these, 21 patients underwent serial venographic imaging using the same modality allowing a direct comparison. Of the 17 patients who had recanalization during follow-up, 10 patients had grade I recanalization, 7 had grade III recanalization, and 4 had no recanalization. Collateral formation was seen in 8 patients: grade I in 3 patients, grade II in 1 patient, and grade III in 4 patients. The proportion of patients with persistent headaches appeared higher in those with no or partial recanalization than with complete recanalization (5 of 14 patients vs. 0 of 7 patients) and in patients with no collaterals than patients with collaterals (4 out of 13 vs. 1 out of 8). None of the patients experienced any recurrence or new symptoms.

Conclusions

Complete or partial recanalization and collateral formation are seen in a prominent proportion of patients with CVST in the months following initial diagnosis. Further studies need to identify the temporal course and clinical significance of venographic recanalization and collateral formation, and factors influencing venographic changes.
Literatur
1.
Zurück zum Zitat Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin. 1992;10:113–24.PubMed Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin. 1992;10:113–24.PubMed
2.
3.
Zurück zum Zitat Ferro JM, Canhao P, Stam J, Bousser M-G, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.CrossRefPubMed Ferro JM, Canhao P, Stam J, Bousser M-G, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.CrossRefPubMed
4.
Zurück zum Zitat Wasay M, Bakshi R, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke. 2001;32:2310–7.CrossRefPubMed Wasay M, Bakshi R, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke. 2001;32:2310–7.CrossRefPubMed
5.
Zurück zum Zitat Summers SM. Transverse sinus thrombosis with hemorrhagic venous infarction treated with thrombectomy, endovascular tissue plasminogen activator, and systemic anticoagulation. J Emerg Med. 2009 [Epub ahead of print]. Summers SM. Transverse sinus thrombosis with hemorrhagic venous infarction treated with thrombectomy, endovascular tissue plasminogen activator, and systemic anticoagulation. J Emerg Med. 2009 [Epub ahead of print].
6.
Zurück zum Zitat Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood. 2006;108:1129–34.CrossRefPubMed Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood. 2006;108:1129–34.CrossRefPubMed
7.
Zurück zum Zitat Stolz E, Trittmacher S, Rahimi A, et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke. 2004;35:544–7.CrossRefPubMed Stolz E, Trittmacher S, Rahimi A, et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke. 2004;35:544–7.CrossRefPubMed
8.
Zurück zum Zitat English JD, Fields JD, Le S, Singh V. Clinical presentation and long-term outcome of cerebral venous thrombosis. Neurocrit Care. 2009;11:330–7.CrossRefPubMed English JD, Fields JD, Le S, Singh V. Clinical presentation and long-term outcome of cerebral venous thrombosis. Neurocrit Care. 2009;11:330–7.CrossRefPubMed
9.
Zurück zum Zitat Qureshi AI, et al. A classification scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol. 2010;2(3):182–3. Qureshi AI, et al. A classification scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol. 2010;2(3):182–3.
10.
Zurück zum Zitat Meijer R, Ihnenfeldt DS, de Groot IJM, et al. Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature. Clin Rehabil. 2003;17:119–29.CrossRefPubMed Meijer R, Ihnenfeldt DS, de Groot IJM, et al. Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature. Clin Rehabil. 2003;17:119–29.CrossRefPubMed
11.
Zurück zum Zitat Oujamaa L, Relave I, Froger J, Mottet D, Pelissier J-Y. Rehabilitation of arm function after stroke. Literature review. Ann Phys Rehabil Med. 2009;52:269–93.PubMed Oujamaa L, Relave I, Froger J, Mottet D, Pelissier J-Y. Rehabilitation of arm function after stroke. Literature review. Ann Phys Rehabil Med. 2009;52:269–93.PubMed
12.
Zurück zum Zitat Rosser N, Floel A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation. 2008;23:95–103.PubMed Rosser N, Floel A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation. 2008;23:95–103.PubMed
13.
Zurück zum Zitat Bonaiuti D, Rebasti L, Sioli P. The constraint induced movement therapy: a systematic review of randomised controlled trials on the adult stroke patients. Eura Medicophys. 2007;43:139–46.PubMed Bonaiuti D, Rebasti L, Sioli P. The constraint induced movement therapy: a systematic review of randomised controlled trials on the adult stroke patients. Eura Medicophys. 2007;43:139–46.PubMed
14.
Zurück zum Zitat Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7:256–67.CrossRefPubMed Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7:256–67.CrossRefPubMed
15.
Zurück zum Zitat Paciaroni M, Palmerini F, Bogousslavsky J. Clinical presentations of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008;23:77–88.PubMed Paciaroni M, Palmerini F, Bogousslavsky J. Clinical presentations of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008;23:77–88.PubMed
16.
Zurück zum Zitat Favrole P, Guichard J-P, Crassard I, Bousser M-G, Chabriat H. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke. 2004;35:99–103.CrossRefPubMed Favrole P, Guichard J-P, Crassard I, Bousser M-G, Chabriat H. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke. 2004;35:99–103.CrossRefPubMed
17.
Zurück zum Zitat Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74:459–61.CrossRefPubMed Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74:459–61.CrossRefPubMed
18.
Zurück zum Zitat Cakmak S, Derex L, Berruyer M, et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175–8.PubMed Cakmak S, Derex L, Berruyer M, et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175–8.PubMed
19.
Zurück zum Zitat Strupp M, Covi M, Seelos K, Dichgans M, Brandt T. Cerebral venous thrombosis: correlation between recanalization and clinical outcome—a long-term follow-up of 40 patients. J Neurol. 2002;249:1123–4.CrossRefPubMed Strupp M, Covi M, Seelos K, Dichgans M, Brandt T. Cerebral venous thrombosis: correlation between recanalization and clinical outcome—a long-term follow-up of 40 patients. J Neurol. 2002;249:1123–4.CrossRefPubMed
20.
Zurück zum Zitat Genevois O, Paques M, Simonutti M, et al. Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci. 2004;45:594–600.CrossRefPubMed Genevois O, Paques M, Simonutti M, et al. Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci. 2004;45:594–600.CrossRefPubMed
21.
Zurück zum Zitat Einhaupl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13:553–9. Einhaupl K, Bousser MG, de Bruijn SF, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13:553–9.
22.
Zurück zum Zitat Klauss V, Spannagl M. Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion. Curr Drug Targets. 2006;7:1285–90. Klauss V, Spannagl M. Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion. Curr Drug Targets. 2006;7:1285–90.
23.
Zurück zum Zitat Jurk K, Schulz AS, Kehrel BE, et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost. 2010;103(5):1053–64.PubMed Jurk K, Schulz AS, Kehrel BE, et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost. 2010;103(5):1053–64.PubMed
24.
Zurück zum Zitat Gresele P, Momi S, Berrettini M, et al. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest. 1998;101:667–76. Gresele P, Momi S, Berrettini M, et al. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest. 1998;101:667–76.
25.
Zurück zum Zitat Momi S, Nasimi M, Colucci M, Nenci GG, Gresele P. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. Haematologica. 2001;86:297–302. Momi S, Nasimi M, Colucci M, Nenci GG, Gresele P. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. Haematologica. 2001;86:297–302.
26.
Zurück zum Zitat Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost. 2010;8:790–8. Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost. 2010;8:790–8.
27.
Zurück zum Zitat Bousser M-G, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6:162–70.CrossRefPubMed Bousser M-G, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6:162–70.CrossRefPubMed
Metadaten
Titel
Occurrence of Post-Acute Recanalization and Collateral Formation in Patients with Cerebral Venous and Sinus Thrombosis. A Serial Venographic Study
verfasst von
Abeer Farrag
Muna Irfan
Gaurav K. Guliani
Nauman Tariq
Robert A. Taylor
M. Fareed K. Suri
Adnan I. Qureshi
Publikationsdatum
01.12.2010
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 3/2010
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-010-9394-6

Weitere Artikel der Ausgabe 3/2010

Neurocritical Care 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.